| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $122.03 | $23.52 | 418.83% | 230.25x | 58.08x | 15.48x | 18.69x | 1.67x | $106.92M | 0.83% | $705.78M | 6.70 | $13.09B | 1,668.53 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.15 | $8.04 | 212.99% | 119.76x | 56.23x | 7.07x | 14.33x | 1.03x | $39.15M | 1.19% | $220.58M | 1.69 | $3.24B | 71.39 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.31 | $16.95 | 350.34% | 71.32x | 65.28x | 7.04x | 9.10x | 1.82x | $182.84M | 3.09% | $654.15M | 8.43 | $5.79B | 48.25 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $219.89 | $78.73 | 179.31% | 36.05x | 32.61x | 6.12x | 21.73x | 1.24x | $793.95M | 2.70% | $1.35B | 10.14 | $30.70B | 26.03 | ||
| HALO | HALOZYME THERAPEUTICS INC | $108.31 | $69.62 | 55.57% | 30.42x | 11.99x | 7.63x | 85.64x | 0.58x | $806.22M | 6.35% | $143.54M | 1.22 | $14.28B | 19.87 | ||
| VCEL | VERICEL CORP | $41.07 | $7.82 | 425.06% | 85.56x | 73.38x | 6.85x | 5.68x | 2.10x | $61.66M | 2.94% | $370.04M | 7.25 | $2.07B | 47.00 | ||
| KRYS | KRYSTAL BIOTECH INC | $334.85 | $82.15 | 307.62% | 40.49x | 42.90x | 22.45x | 7.29x | 2.16x | $257.78M | 2.61% | $1.36B | 46.03 | $9.49B | 40.69 | ||
| RPRX | ROYALTY PHARMA PLC | $56.66 | $35.40 | 60.07% | 30.14x | 10.36x | 9.94x | 3.33x | 0.61x | $2.92B | 11.59% | $9.79B | 21.99 | $40.73B | 34.63 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.70 | $7.45 | 43.69% | 11.26x | 9.83x | 4.65x | 2.92x | 0.98x | $82.01M | 12.95% | $217.65M | 3.68 | $491.58M | 6.36 | ||
| TGTX | TG THERAPEUTICS INC | $53.91 | $21.93 | 145.78% | 17.50x | 54.25x | 9.56x | 13.66x | 1.95x | $17.39M | 0.23% | $604.08M | 4.26 | $8.52B | 61.20 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $57.54 | $18.23 | 215.60% | 151.42x | 19.89x | 3.27x | 1.76x | 1.01x | $738.18M | 6.63% | $6.32B | 32.68 | $14.45B | 37.47 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $236.04 | $176.37 | 33.83% | 15.47x | 9.24x | 3.24x | 3.19x | 0.64x | $1.62B | 10.86% | $4.80B | 75.98 | $18.10B | 11.20 | ||
| EXEL | EXELIXIS INC | $58.85 | $29.36 | 100.47% | 17.89x | 17.79x | 6.06x | 7.91x | 1.18x | $1.17B | 7.94% | $1.84B | 7.35 | $14.47B | 13.30 | ||
| MDXG | MIMEDX GROUP INC | $4.55 | $1.25 | 265.28% | 113.75x | -26.24x | 1.89x | 3.07x | 1.23x | $44.50M | 6.62% | $216.00M | 1.46 | $544.58M | 23.88 | ||
| ADMA | ADMA BIOLOGICS INC | $10.11 | $6.83 | 48.09% | 14.04x | 12.71x | 4.50x | 5.55x | 0.82x | $116.47M | 5.04% | $408.21M | 1.79 | $2.33B | 9.98 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $306.77 | $84.00 | 265.22% | 30.46x | 32.47x | 21.18x | 6.32x | 2.31x | $130.62M | 2.12% | $967.52M | 48.22 | $6.24B | 22.37 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $503.50 | $145.16 | 246.86% | 29.05x | 26.30x | 10.15x | 6.30x | 2.18x | $3.80B | 2.97% | $20.25B | 79.81 | $123.45B | 22.43 | ||
| UTHR | UNITED THERAPEUTICS CORP | $536.40 | $184.55 | 190.66% | 17.74x | 20.07x | 7.24x | 3.59x | 3.25x | $1.09B | 4.78% | $6.40B | 150.24 | $21.20B | 12.65 | ||
| TECH | BIO-TECHNE CORP | $72.58 | $15.93 | 355.56% | 62.03x | 34.93x | 9.32x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.41B | 32.81 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.92 | $29.44 | 35.58% | 12.71x | 9.58x | 2.41x | 2.33x | 0.76x | $354.90M | 15.35% | $999.24M | 17.25 | $1.93B | 6.89 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $726.47 | $418.67 | 73.52% | 17.32x | 12.95x | 4.81x | 2.36x | 0.92x | $3.76B | 5.04% | $31.71B | 308.48 | $75.04B | 13.05 | ||
| VCYT | VERACYTE INC | $47.67 | $11.47 | 315.45% | 33.10x | 24.51x | 6.78x | 2.76x | 2.78x | $165.99M | 4.35% | $1.39B | 17.36 | $3.57B | 25.57 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.16 | $1.36 | -14.58% | 8.29x | -2.61x | 1.43x | 1.53x | 0.46x | $19.58M | 29.14% | $44.20M | 0.76 | $18.82M | 2.46 | ||
| INCY | INCYTE CORP | $114.13 | $57.64 | 98.02% | 14.06x | 32.19x | 3.93x | 3.65x | 1.58x | $1.92B | 8.40% | $6.34B | 31.66 | $19.18B | 9.28 |